The Week Ahead: COS...
Health Care: Drugs
Quidel Corporation (QDEL: NASDAQ)
$22.62 0.52 | 2.35%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 4.99M | 7.63M | -11.27M | 32.88M |
| Operating Gains/Losses | 101.00K | 368.00K | 9.00K | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 167.00K | 8.18M | -1.12M | 15.60M |
| (Increase) Decrease in Inventories | -1.08M | 3.05M | 2.42M | -3.34M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -16.38M | -1.04M | -2.60M | 924.00K |
| (Decrease) Increase In Other Current Liabilities | 839.00K | 1.05M | -12.30M | 12.78M |
| (Increase) Decrease In Other Working Capital | 2.80M | -72.00K | -4.64M | 3.30M |
| Other Non-Cash Items | 5.50M | 9.13M | 6.18M | 3.09M |
| Net Cash From Continuing Operations | 19.63M | 46.98M | -10.29M | 72.84M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 19.63M | 46.98M | -10.29M | 72.84M |
| Sale of Property, Plant & Equipment | 122.00K | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 4.00M | 0.00 |
| Purchases of Property, Plant & Equipment | -27.72M | -20.79M | -10.48M | -7.10M |
| Acquisitions | -1.00M | 0.00 | -128.14M | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -4.00M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 81.00K | -126.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -28.60M | -20.79M | -134.54M | -11.22M |
| Issuance of Debt | 0.00 | 0.00 | 75.00M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 4.66M | 59.24M | 1.15M | 1.86M |
| Repayment of Long-Term Debt | -38.83M | -30.28M | -3.20M | -238.00K |
| Repurchase of Capital Stock | -3.41M | -626.00K | -9.18M | -33.51M |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 61.00K | 12.00K | -1.15M | 1.37M |
| Net Cash From Financing Activities | -37.51M | 28.35M | 62.62M | -30.52M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -46.48M | 54.54M | -82.22M | 31.10M |
Portfolios with QDEL
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- Contributor2011 Santa Claus Rally Stra...
- UserMatt Picks
- ContributorBarron's Insider Purchases ...
- UserPART 7 JPMorgan 28th Annual...
- ContributorBarron's Insider Purchases ...
Latest QDEL Headlines from TheStreet
- Quidel Corporation Stock Upgraded (QDEL) 02.14.13 | 04:02 am
- Quidel's CEO Presents At Canaccord Genuity 32nd Annual Growth Conference (Transcript) 08.14.12 | 04:08 pm
- Quidel Corporation Stock Downgraded (QDEL) 07.30.12 | 05:07 am
- Quidel's CEO Discusses Q2 2012 Results - Earnings Call Transcript 07.26.12 | 01:07 am
- Quidel's CEO Presents At Goldman Sachs Healthcare Conference (Transcript) 06.06.12 | 08:06 pm
- Quidel's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.25.12 | 11:04 pm
- Quidel Stock Hits New 52-Week High (QDEL) 04.03.12 | 11:04 am
- 5 Stocks Insiders Love Right Now 03.29.12 | 12:03 pm
- Quidel Corporation Stock Upgraded (QDEL) 03.29.12 | 05:03 am
- Insiders Trading SPB, EXPR, QDEL 03.22.12 | 09:03 am
Press Releases for QDEL
- Quidel And Life Technologies Receive FDA Clearance For Clostridium Difficile Assay And QuantStudioâ¿¢ Dx And 7500 Fast Dx Real-Time PCR Instruments - PR Newswire 03.18.13 | 08:03 am
- Quidel Reports Fourth Quarter And Full Year 2010 Results - Business Wire 02.24.11 | 04:02 pm
- Quidel To Present At JP Morgan 29th Annual Healthcare Conference - Business Wire 01.07.11 | 01:01 pm
- Quidel Announces Pricing Of Common Shares Offering - Business Wire 01.06.11 | 09:01 am
- Quidel Announces Proposed Common Shares Offering - Business Wire 01.05.11 | 04:01 pm
- Quidel Reports Third Quarter 2010 Results - Business Wire 10.27.10 | 04:10 pm
- Quidel To Hold Third Quarter 2010 Results Conference Call On October 27, 2010 - Business Wire 10.13.10 | 07:10 pm
- Quidel Announces FDA Clearance Of Its QuickVue® RSV 10 Immunoassay Diagnostic Test - Business Wire 09.29.10 | 07:09 am
- Quidel Announces FDA Clearance Of Its RapidVue® HCG Pregnancy Lateral Flow Diagnostic Test - Business Wire 08.31.10 | 04:08 pm
- Quidel To Present At Canaccord Genuity 30th Annual Growth Conference - Business Wire 08.04.10 | 06:08 pm
Partner Headlines for QDEL
- UPDATE: Piper Jaffray Initiates Quidel at Overweight on Long-Term Outlook - Benzinga 10.04.12 | 01:10 pm
- FDA Nod for Quidel's hMPV Test - Analyst Blog - Zacks 12.27.11 | 06:12 pm
- Quidel Receives CE Mark for Its Sofia Strep A Fluorescent Immunoassay Test - Benzinga 12.01.11 | 01:12 pm
- Quidel Receives 510(k) Clearance of Its Sofia Fluorescent - Benzinga 10.26.11 | 01:10 pm
- Wedbush Lowers Q3 Estimate on Quidel - Benzinga 10.26.11 | 09:10 am
- 8 Oversold, Shorted Stocks Reporting Earnings Next Week, Being Bought By Smart Money - Seeking Alpha 07.28.11 | 09:07 am
- Insider Buying: 8 Recent CEO Buys of More Than $100,000 - Seeking Alpha 06.10.11 | 09:06 am
- UPDATE 1-Quidel sees Q4 revenue below Street view; shrs down - Reuters 01.05.11 | 05:01 pm
- Torpedo Watch List: Large and Small Cap Stocks to Avoid - Seeking Alpha 11.17.10 | 06:11 am
- 9 Stocks That Should Be on Every Contrarian's Radar - Seeking Alpha 09.10.10 | 05:09 pm
